Combination of rocaglamide and apoptosis inducing substances for the treatment of cancer

Patent Number: 9387192

Patent Date: 2016-07-12

Patent type: utility

The present invention relates to a combined preparation comprising at least one rocaglamide derivative and at least one apoptosis inducing agent, preferably from the group of substances comprising agents inducing the extrinsic apoptotic pathway, antiproliferative agents and agents which induce apoptosis in T-cells by activation induced cell death (AICD) for the treatment of cancer.


First Name Last Name City State Country
Peter H. Krammer - - -
Min Li-Weber - - -


Section Class Sub Class Group Sub Group
A 61 K 31 343
A 61 K 39 395
A 61 K 45 06


Organization First Name Last Name City State Country
DKFZ Deutsches Krebsforschungszentrum - - - - -